Inhibition of oxaliplatin-induced neurotoxicity by silymarin through increased expression of brain-derived neurotrophic factor and inhibition of p38-MAPK
- 29 March 2019
- journal article
- research article
- Published by Springer Nature in Molecular & Cellular Toxicology
- Vol. 15 (2) , 145-152
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Silymarin induces a multi-targeted cell death process in the human colon cancer cell line HT-29Biomedicine & Pharmacotherapy, 2017
- The Potential of Flavonolignans in Prostate Cancer ManagementCurrent Medicinal Chemistry, 2016
- Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?Neuroscience Letters, 2015
- Enhancement of oxaliplatin-induced cell apoptosis and tumor suppression by 3-methyladenine in colon cancerOncology Letters, 2015
- Neuroprotective Potential of Silymarin against CNS Disorders: Insight into the Pathways and Molecular Mechanisms of ActionCNS Neuroscience & Therapeutics, 2013
- Silybin and the liver: From basic research to clinical practiceWorld Journal of Gastroenterology, 2011
- Neurotoxicity From Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: NSABP C-07Journal of Clinical Oncology, 2007
- Advances in the Use of Milk Thistle (Silybum marianum)Integrative Cancer Therapies, 2007
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal CancerJournal of Clinical Oncology, 2004